Latest
-
FDA Approves World’s First Chikungunya Vaccine- Valneva’s Single Dose IXCHIQ
IXCHIQ has received the approval of the United States Food and Drug Administration (US FDA) for use in adults who are 18 years and older.
-
National Epilepsy Day 2023: Date, Theme, Significance and Importance
By observing National Epilepsy Day, we contribute to a society that embraces diversity and understands the issues faced by people with epilepsy.
-
Next Pandemic On The Way? Scientists Believe Virus Group That Includes Measles, Nipah Virus Could Be The Cause
As flu and coronavirus have taken the spotlight, paramyxoviruses have been brewing in the background with the potential to cause the next pandemic.
-
Jagran New Media collaborates with Google Cloud to launch a 3 day Hackathon
#HackTheFuture: Marathon of the Minds will see participation from IIT Kanpur students.
-
Pune City Reports First Case Of Zika Virus This Year: Here Are Some Complications Of ZiV You Should Know
The major issue with Zika Virus is that most infected people do not show any symptoms, but are capable of transmitting ZiV to others around them.
-
Abdominal Obesity Poses Higher Heart Attack Risk, Regardless of Overall Weight
These findings underscore the necessity of focusing on abdominal obesity as a key factor in heart health assessments. Read ahead to know.
-
Do You Work From Home? Study Suggests It May Increase Your Risk of THESE two Mental Illnesses
The study highlights the need for a balanced approach to remote work, to safeguard both the mental and physical health of people in the workforce.
-
India Battles Diabetes Crisis, Ranks Second-Highest Global Prevalence
The survey highlights that India is also grappling with a burden of high BP, affecting a staggering 315 million people. Read on.
-
Omicron Variant HV.1 Sparks Concerns Across the Nation; Surge in 'COVID Tongue' Cases Raises New Health Alarms
The total COVID case tally is 4.50 crore, with a recovery rate of 98.81%. The death toll stands at 5,33,295. Read ahead to know more.
-
New Study Reveals Potential Rebound Risk with Paxlovid in COVID-19 Patients
Patients using Paxlovid are encouraged to be aware of potential risks, although the benefits in preventing hospitalisations and deaths are substantial.